The word “bootstrapped” understates the challenge in pharmaceutical contexts. Building without venture capital or private equity is difficult in any industry. In pharmaceuticals, where regulatory compliance, clinical credibility, supply chain infrastructure, and product licensing are all prerequisites for operating, removing institutional backing means absorbing every setback with no buffer between a founder’s decisions and their full financial consequences.
Barry Patel and Wade Smith built Galt Companies under exactly those conditions. When the COVID-19 pandemic arrived, the direct healthcare provider engagement that Galt Phranchise System depended on became operationally impossible. Phranchisees could not walk into physician offices. Educational conversations built over months of relationship development had no immediate substitute. Every commercial channel the company had constructed was disrupted simultaneously.
What followed was not a pivot. Galt did not abandon the model when circumstances made it harder to pursue. The mission, giving pain patients access to non-opioid alternatives through community-based local operators, did not become less urgent because the delivery of it became more complicated. The company worked through the disruption with what Patel later described plainly: resilience and adaptability, the product of a founding culture that had never had the luxury of assuming things would be easy.
That period of strain produced something durable. Every product launch, every Phranchisee brought to operational stability, every territory navigated through regulatory complexity generated organizational knowledge that compounded. By 2024, Galt was reporting the strongest year in its history. The portfolio had grown from a single product to a multi-therapeutic lineup. Licensed territory activity had expanded into Texas, Georgia, New York, Louisiana, and additional states. Chief Franchise Officer Mike Harley, who joined in 2023 with four decades of franchise experience built across multiple industries, had constructed the operational support infrastructure the model needed to scale consistently.
Ernst & Young took formal notice in April 2025, naming Patel and Smith among 36 finalists for the EY Entrepreneur of the Year Southeast Award, recognizing their entrepreneurial spirit, purpose, and the kind of lasting impact that institutional capital cannot substitute for. The recognition arrived because of what the founders had built across nearly a decade without that capital, not despite it.
Smith has articulated the underlying principle without ornamentation. When there is no institutional buffer between a decision and its outcome, the quality of the thinking has to be higher. At Galt, it was.